Tempest Therapeutics, Inc. (TPST) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 11.91M |
| Enterprise Value | 12.34M |
| P/E Ratio | -0.12 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -7.38 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.39 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -4.2 |
| Return On Equity | -12.7 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -25.79M |
| Net Income | -26.26M |
| Diluted EPS | -6.33 |
Balance Sheet
| Total Cash | 779,000 |
| Total Cash/Share | 0.05 |
| Total Debt | 7.56M |
| Total Debt/Equity | -6.94 |
| Current Ratio | 0.38 |
| Book Value Per Share | -0.07 |
Price History
| 52-Week Change | -94.98 |
| 52-Week High | 11.13 |
| 52-Week Low | 0.52 |
| Moving Average 50 Days | 0.91 |
| Moving Average 200 Days | 1.6 |
Statistics
| Average Volume | 2.58M |
| Shares Outstanding | 16.89M |
| % Held by Institutions | 6.73 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:13 |
| Last Split Date | April 09, 2025 |
AD
